|
Most frequently cited recent ERJ articles
Thomson ISI evaluates and compares the impact of scholarly and scientific journals, using citation data from over 7,500 publications. According to Thomson, the current impact factor of the ERJ currently stands at 5.545, making it the third leading journal in the field.
The most frequently cited recent ERJ original articles as assessed by Thomson are as follows:
| 1. |
Brauer M, Hoek G, Smit HA, et al. |
 |
|
Air pollution and development of asthma, allergy and infections in a birth cohort |
|
|
Eur Respir J 2007; 29: 879-888.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 2. |
Kobashi Y, Mouri K, Obase Y, et al. |
|
|
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients |
|
|
Eur Respir J 2007; 30: 945-950.
[Abstract]
[Full text]
[PDF]
|
| |
| 3. |
Dodge JA, Lewis PA, Stanton M, et al. |
|
|
Cyctic fibrosis mortality and survival in the UK: 1947-2003 |
|
|
Eur Respir J 2007; 29: 522-526.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 4. |
Perera WR, Hurst JR, Wilkinson TMA, et al. |
|
|
Inflammatory changes, recovery and recurrence at COPD exacerbation |
|
|
Eur Respir J 2007; 29: 527-534.
[Abstract]
[Full text]
[PDF]
|
| |
| 5. |
Humbert M, Segal ES, Kiely DG, et al. |
|
|
Results of European post-marketing surveillance of bosentan in pulmonary hypertension |
|
|
Eur Respir J 2007; 30: 338-344.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 6. |
Søyseth V, Brekke PH, Smith P, et al. |
|
|
Statin use is associated with reduced mortality in COPD |
|
|
Eur Respir J 2007; 29: 279-283.
[Abstract]
[Full text]
[PDF]
|
| |
| 7. |
Mathai SC, Girgis RE, Fisher MR, et al. |
|
|
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension |
|
|
Eur Respir J 2007; 29: 469-475.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 8. |
Migliori GB, Lange C, Centis R, et al. |
|
|
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases |
|
|
Eur Respir J 2007; 31: 1155-1199.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 9. |
Judson MA, Baughman RP, Costabel U, et al. |
|
|
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial |
|
|
Eur Respir J 2008; 31: 1189-1196.
[Abstract]
[Full text]
[PDF]
|
| |
| 10. |
Schulz R, Blau A, Börgel J, et al. |
|
|
Sleep apnoea in heart failure |
|
|
Eur Respir J 2008; 29: 1201-1205.
[Abstract]
[Full text]
[PDF]
|
The most frequently cited recent ERJ review articles as assessed by Thomson are as follows:
| 1. |
Bateman ED, Hurd SS, Barnes PJ, et al. |
|
|
Global strategy for asthma management and prevention: GINA executive summary |
|
|
Eur Respir J 2008; 31: 143-178.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 2. |
McNicholas WT, Bonsignore MR and the Management Committee of EU COST ACTION B26 |
|
|
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities |
|
|
Eur Respir J 2007; 29: 156-178.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 3. |
Brand PLP, Baraldi E, Bisgaard H, et al. |
|
|
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach |
|
|
Eur Respir J 2008; 32: 1096-1110.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 4. |
Morice AH, Fontana GA, Belvisi MG, et al. |
|
|
ERS guidelines on the assessment of cough |
|
|
Eur Respir J 2007; 29: 1256-1276.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 5. |
Cazzola M, MacNee W, Martinez FJ, et al. |
|
|
Outcomes for COPD pharmacological trials: from lung function to biomarkers |
|
|
Eur Respir J 2007; 31: 416-468.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 6. |
James AL and Wenzel S |
|
|
Clinical relevance of airway remodelling in airway diseases |
|
|
Eur Respir J 2007; 30: 134-155.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 7. |
Fabbri LM, Luppi F, Beghé B, et al. |
|
|
Complex chronic comorbidities of COPD |
|
|
Eur Respir J 2007; 31: 204-212.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 8. |
Suissa S, Ernst P, Vandemheen KL and Aaron SD |
|
|
Methodological issues in therapeutic trials of COPD |
|
|
Eur Respir J 2008; 31: 927-933.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 9. |
Cambon-Thomsen A, Rial-Sebbag E and Knoppers BM |
|
|
Trends in ethical and legal frameworks for the use of human biobanks |
|
|
Eur Respir J 2007; 30: 373-382.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
| 10. |
Taylor DR, Bateman ED, Boulet L-P, et al. |
|
|
A new perspective on concepts of asthma severity and control |
|
|
Eur Respir J 2008; 32: 545-554.
[Abstract]
[Full text]
[PDF]
|
|
|
| |
Back to Top
Copyright © 2009 by the European Respiratory Society.
|
|
